Literature DB >> 11914998

Definitions of cytomegalovirus infection and disease in transplant recipients.

Per Ljungman1, Paul Griffiths, Carlos Paya.   

Abstract

Cytomegalovirus (CMV) infection and disease are important causes of morbidity and mortality among transplant recipients. For the purpose of developing consistent reporting of CMV in clinical trials, definitions of CMV infection and disease were developed and published. This study seeks to update the definitions of CMV on the basis of recent developments in diagnostic techniques, as well as to add to these definitions the concept of indirect effects caused by CMV.

Entities:  

Mesh:

Year:  2002        PMID: 11914998     DOI: 10.1086/339329

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  273 in total

Review 1.  Management of cytomegalovirus infection in solid organ transplantation.

Authors:  Camille N Kotton
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry.

Authors:  Roy F Chemaly; Belinda Yen-Lieberman; Elias A Castilla; Amy Reilly; Susana Arrigain; Carol Farver; Robin K Avery; Steven M Gordon; Gary W Procop
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.

Authors:  Margaret L Green; Wendy Leisenring; Daniel Stachel; Steven A Pergam; Brenda M Sandmaier; Anna Wald; Lawrence Corey; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-07       Impact factor: 5.742

4.  Introduction: disease overview and risk factors.

Authors: 
Journal:  P T       Date:  2010-03

Review 5.  Fulminant gastrointestinal graft-versus-host disease concomitant with cytomegalovirus infection: case report and literature review.

Authors:  Hidetaka Okubo; Naoyoshi Nagata; Naomi Uemura
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

6.  Gastrointestinal Infections Caused by Cytomegalovirus.

Authors:  David A. Bobak
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

7.  Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.

Authors:  Raphael Carapito; Ismail Aouadi; Angélique Pichot; Perrine Spinnhirny; Aurore Morlon; Irina Kotova; Cécile Macquin; Véronique Rolli; Anne Cesbron; Katia Gagne; Machteld Oudshoorn; Bronno van der Holt; Myriam Labalette; Eric Spierings; Christophe Picard; Pascale Loiseau; Ryad Tamouza; Antoine Toubert; Anne Parissiadis; Valérie Dubois; Catherine Paillard; Myriam Maumy-Bertrand; Frédéric Bertrand; Peter A von dem Borne; Jürgen H E Kuball; Mauricette Michallet; Bruno Lioure; Régis Peffault de Latour; Didier Blaise; Jan J Cornelissen; Ibrahim Yakoub-Agha; Frans Claas; Philippe Moreau; Dominique Charron; Mohamad Mohty; Yasuo Morishima; Gérard Socié; Seiamak Bahram
Journal:  Bone Marrow Transplant       Date:  2020-04-14       Impact factor: 5.483

8.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

9.  Cytomegalovirus infection in childhood-onset systemic lupus erythematosus.

Authors:  Evelyn V Rozenblyum; Upton D Allen; Earl D Silverman; Deborah M Levy
Journal:  Int J Clin Rheumtol       Date:  2013-02

10.  Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver Transplantation.

Authors:  Emanuele Nicastro; Sara Giovannozzi; Paola Stroppa; Valeria Casotti; Anna Paola Callegaro; Alessandra Tebaldi; Claudio Farina; Michele Colledan; Lorenzo DʼAntiga
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.